464175-15-3

Upstream product

• 501-53-1 benzyl chloroformate 
• 464175-13-1 4-(4-chloro-butyl)-piperidine 

Downstream Products

• 464175-16-4 4-{4-[4-(2-tert-butoxycarbonylamino-2-carboxy-ethyl)-phenoxy]-butyl}-piperidine-1-carboxylic acid benzyl ester 
• 464175-19-7 4-(4-{4-[(S)-2-Benzyloxycarbonyl-2-(4-butylcarbamoyl-benzenesulfonylamino)-ethyl]-phenoxy}-butyl)-piperidine-1-carboxylic acid benzyl ester 
• 464175-18-6 4-(4-{4-[(S)-2-Benzyloxycarbonyl-2-(4-carboxy-benzenesulfonylamino)-ethyl]-phenoxy}-butyl)-piperidine-1-carboxylic acid benzyl ester 
• 464175-17-5 4-{4-[4-(2-benzyloxycarbonyl-2-tert-butoxycarbonylamino-ethyl)-phenoxy]-butyl}-piperidine-1-carboxylic acid benzyl ester 
• 864680-93-3 4-{4-[4-((S)-2-Amino-2-benzyloxycarbonyl-ethyl)-phenoxy]-butyl}-piperidine-1-carboxylic acid benzyl ester 

Relevant academic research and scientific papers

Synthesis of RGD analogs as potential vectors for targeted drug delivery

RGD analogs bind to integrin receptors with high affinity and therefore have the potential to be used as vectors for the targeted delivery of pharmaceutical agents to designated sites. Critical to this application is the ability to synthesize RGD analogs